\relax 
\bibstyle{plos2009}
\citation{Bushue:2010aa,Tang:2011aa,Cheung:2012aa}
\citation{Nilsson:1984aa}
\citation{Warrell:1993aa,Freemantle:2003aa}
\citation{Breitman1980}
\citation{Yen1998}
\citation{Hong2001}
\citation{Mangelsdorf1990}
\citation{Hong2001}
\citation{Congleton:2012fk,Shen:2011aa,Shen2009,Yen2006,Marchisio:1998aa}
\citation{Congleton2011,WANG2004}
\citation{YEN1990}
\citation{WANG2004}
\citation{WANG2004}
\citation{Yang2002}
\citation{Wang2008}
\citation{Wang2008}
\citation{Wang2008}
\citation{Tasseff2011}
\citation{Tasseff2011}
\citation{Wang2008,Katagiri1994}
\citation{Miranda2007}
\citation{Congleton:2012fk}
\citation{Shen2009}
\citation{Yen1998}
\citation{Hickstein1989}
\citation{Congleton2011}
\citation{Hornstein:2004aa}
\citation{Song1996}
\citation{Costello1999,Graham2007}
\citation{Shen2009}
\citation{Cleghon1994}
\citation{Zimmermann1999}
\citation{Ritt2007}
\citation{Hekman2004}
\citation{Dhillon2009}
\citation{Song1996}
\citation{Costello1999,Graham2007}
\citation{Graham2007}
\citation{Shen2009}
\citation{Kim2009,Milanini-Mongiat2002,Zhang2004,Li2006}
\citation{YEN1984}
\citation{Ferrell:2002aa}
\citation{Xiong:2003aa}
\citation{Bagci:2006aa}
\citation{Luan:2007aa}
\citation{pr3010138}
\citation{Milo:2010aa}
\newlabel{eqn:objective-function}{{12}{19}}
\newlabel{norm_exp_data}{{13}{19}}
\citation{Julia,Hindmarsh2005}
\citation{Brooks1996}
\bibdata{Paper_v1}
\bibcite{Bushue:2010aa}{{1}{}{{}}{{}}}
\bibcite{Tang:2011aa}{{2}{}{{}}{{}}}
\bibcite{Cheung:2012aa}{{3}{}{{}}{{}}}
\bibcite{Nilsson:1984aa}{{4}{}{{}}{{}}}
\bibcite{Warrell:1993aa}{{5}{}{{}}{{}}}
\bibcite{Freemantle:2003aa}{{6}{}{{}}{{}}}
\bibcite{Breitman1980}{{7}{}{{}}{{}}}
\bibcite{Yen1998}{{8}{}{{}}{{}}}
\bibcite{Hong2001}{{9}{}{{}}{{}}}
\bibcite{Mangelsdorf1990}{{10}{}{{}}{{}}}
\bibcite{Congleton:2012fk}{{11}{}{{}}{{}}}
\bibcite{Shen:2011aa}{{12}{}{{}}{{}}}
\bibcite{Shen2009}{{13}{}{{}}{{}}}
\bibcite{Yen2006}{{14}{}{{}}{{}}}
\bibcite{Marchisio:1998aa}{{15}{}{{}}{{}}}
\bibcite{Congleton2011}{{16}{}{{}}{{}}}
\bibcite{WANG2004}{{17}{}{{}}{{}}}
\bibcite{YEN1990}{{18}{}{{}}{{}}}
\bibcite{Yang2002}{{19}{}{{}}{{}}}
\bibcite{Wang2008}{{20}{}{{}}{{}}}
\bibcite{Tasseff2011}{{21}{}{{}}{{}}}
\bibcite{Katagiri1994}{{22}{}{{}}{{}}}
\bibcite{Miranda2007}{{23}{}{{}}{{}}}
\bibcite{Hickstein1989}{{24}{}{{}}{{}}}
\bibcite{Hornstein:2004aa}{{25}{}{{}}{{}}}
\bibcite{Song1996}{{26}{}{{}}{{}}}
\bibcite{Costello1999}{{27}{}{{}}{{}}}
\bibcite{Graham2007}{{28}{}{{}}{{}}}
\bibcite{Cleghon1994}{{29}{}{{}}{{}}}
\bibcite{Zimmermann1999}{{30}{}{{}}{{}}}
\bibcite{Ritt2007}{{31}{}{{}}{{}}}
\bibcite{Hekman2004}{{32}{}{{}}{{}}}
\bibcite{Dhillon2009}{{33}{}{{}}{{}}}
\bibcite{Kim2009}{{34}{}{{}}{{}}}
\bibcite{Milanini-Mongiat2002}{{35}{}{{}}{{}}}
\bibcite{Zhang2004}{{36}{}{{}}{{}}}
\bibcite{Li2006}{{37}{}{{}}{{}}}
\bibcite{YEN1984}{{38}{}{{}}{{}}}
\bibcite{Ferrell:2002aa}{{39}{}{{}}{{}}}
\bibcite{Xiong:2003aa}{{40}{}{{}}{{}}}
\bibcite{Bagci:2006aa}{{41}{}{{}}{{}}}
\bibcite{Luan:2007aa}{{42}{}{{}}{{}}}
\bibcite{pr3010138}{{43}{}{{}}{{}}}
\bibcite{Milo:2010aa}{{44}{}{{}}{{}}}
\bibcite{Julia}{{45}{}{{}}{{}}}
\bibcite{Hindmarsh2005}{{46}{}{{}}{{}}}
\bibcite{Brooks1996}{{47}{}{{}}{{}}}
\bibcite{Jensen:2015aa}{{48}{}{{}}{{}}}
\citation{Wang2008}
\citation{Wang2008}
\citation{Jensen:2015aa}
\citation{Jensen:2015aa}
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces Schematic of the effective ATRA differentiation circuit. Above a critical threshold, ATRA activates an upstream Trigger, which induces signalsome complex formation. Signalsome activates the mitogen-activated protein kinase (MAPK) cascade which in turn drives the differentiation program and signalsome formation. Both Trigger and activated cRaf-pS621 drive a phenotype gene expression program responsible for differentiation. Trigger activates the expression of a series of transcription factors which in combination with cRaf-pS621 result in phenotypic change.\relax }}{28}}
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig:network}{{1}{28}}
\@writefile{lof}{\contentsline {figure}{\numberline {2}{\ignorespaces Model analysis for ATRA-induced HL-60 differentiation. A: BLR1 mRNA versus time following exposure to 1$\mu $M ATRA at t = 0 hr. B: cRaf-pS621 versus time following exposure to 1$\mu $M ATRA at t = 0 hr. Points denote experimental measurements, solid lines denote the mean model performance. Shaded regions denote the 99\% confidence interval calculated over the parameter ensemble. C: Signalsome and cRaf-pS621 nullclines for ATRA below the critical threshold. The model had two stable steady states and a single unstable state in this regime. D: Signalsome and cRaf-pS621 nullclines for ATRA above the critical threshold. In this regime the model had only a single stable steady state. E: Morphology of HL-60 as a function of ATRA concentration (t = 72 hr). \relax }}{29}}
\newlabel{fig:model-fitting}{{2}{29}}
\@writefile{lof}{\contentsline {figure}{\numberline {3}{\ignorespaces Model simulation following exposure to 1$\mu $M ATRA. A: BLR1 mRNA versus time with and without MAPK inhibitor. B: cRaf-pS621 versus time following pulsed exposure to 1$\mu $M ATRA with and without BLR1. Solid lines denote the mean model performance, while shaded regions denote the 99\% confidence interval calculated over the parameter ensemble. C: Western blot analysis of phosphorylated ERK1/2 in ATRA washout experiments. Experimental data in panels A and B were reproduced from Wang and Yen \cite  {Wang2008}, data in panel C is reported in this study. \relax }}{30}}
\newlabel{fig:model-predictions}{{3}{30}}
\@writefile{lof}{\contentsline {figure}{\numberline {4}{\ignorespaces Model simulation of the HL-60 gene expression program following exposure to 1$\mu $M ATRA at t = 0 hr. A: CD38 and CD11b expression versus time following ATRA exposure at time t = 0 hr. B: Gene expression at t = 48 hr following ATRA exposure. Experimental data in panels A and B were reproduced from Jensen et al. \cite  {Jensen:2015aa}.\relax }}{31}}
\newlabel{fig:model-grn-simulations}{{4}{31}}
\@writefile{lof}{\contentsline {figure}{\numberline {5}{\ignorespaces Investigation of a panel of possible Raf interaction partners in the presence and absence of ATRA. A: Species identified to precipitate out with Raf: first column shows Western blot analysis on total Raf immunoprecipitation with and without 24 hr ATRA treatment and the second on total lysate. B: The expression of species considered that did not precipitate out with Raf at levels detectable by Western blot analysis on total lysate. C: Effect of the Raf inhibitor GW5074 on Raf interactions as determined by Western blot analysis of total Raf immunoprecipitation. The Authors note the the signal associated with Src was found to be weak. D: Cell Cycle distribution as determined by flow cytometry indicated arrest induced by ATRA, which was increased by the addition of GW5074. E: Expression of the cell surface marker CD11b as determined by flow cytometry indicated increased expression induced by ATRA, which was enhanced by the addition of GW5074. F: Inducible reactive oxygen species (ROS) as determined by DCF flow cytometry. The functional differentiation response of ATRA treated cells was mitigated by GW5074.\relax }}{32}}
\newlabel{fig:ip-data}{{5}{32}}
\providecommand\NAT@force@numbers{}\NAT@force@numbers
